FDA Approval of Dupixent for COPD by September 27, 2024? | Binary | | | 7 months ago | |
Will Dupixent sales grow in Q4 2024? | Binary | | | 7 months ago | |
Will Dupixent receive additional approvals for new indications by end of 2024? | Binary | | | 7 months ago | |
Market Share of Dupixent in COPD Treatments in Europe by end of 2024 | Categorical | | | 7 months ago | |
Sanofi Stock Price Change Within One Week After FDA Decision on Dupixent | Categorical | | | 7 months ago | |
Dupixent's Ranking Among Top-Selling Drugs Worldwide in 2024 | Categorical | | | 7 months ago | |
Number of EU countries adopting seladelpar in health systems by December 31, 2025 | Categorical | | | 10 days ago | |
Will the European Commission approve seladelpar for PBC by March 31, 2025? | Binary | | | 10 days ago | |
Will seladelpar be launched in the EU market for PBC by June 30, 2025? | Binary | | | 10 days ago | |
Will seladelpar achieve over 50% market share in the EU PBC treatment market by December 31, 2025? | Binary | | | 10 days ago | |
Seladelpar's approval status by EMA and FDA by December 31, 2025 | Categorical | | | 10 days ago | |
Seladelpar's impact on ALP levels in follow-up studies by December 31, 2025 | Categorical | | | 10 days ago | |
